University Hospital Antwerp
🇧🇪Belgium
Clinical Trials
222
Active:9
Completed:107
Trial Phases
5 Phases
Phase 1:9
Phase 2:11
Phase 3:7
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (149 trials with phase data)• Click on a phase to view related trials
Not Applicable
96 (64.4%)Phase 4
26 (17.4%)Phase 2
11 (7.4%)Phase 1
9 (6.0%)Phase 3
7 (4.7%)NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
Not Applicable
Recruiting
- Conditions
- Pleural Epithelioid MesotheliomaMesothelioma; PleuraNeoadjuvant Chemoimmunotherapy
- Interventions
- Drug: Neoadjuvant chemo-immunotherapyProcedure: Extended pleurectomy/decortication in case of reaching operability
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 37
- Registration Number
- NCT07121374
- Locations
- 🇧🇪
University Hospital Antwerp, Edegem, Antwerp, Belgium
Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection
Recruiting
- Conditions
- Postoperative Pain ManagementRATS Surgery
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 6
- Registration Number
- NCT07099469
- Locations
- 🇧🇪
University Hospital Antwerp, Edegem, Antwerp, Belgium
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
Not Applicable
Recruiting
- Conditions
- Endothelial Function (FMD)PreeclampsiaRetinal Vessels
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 60
- Registration Number
- NCT07084727
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Antwerp, Belgium
Clinical Evaluation of the Femiset Device for Perineal Descent in Women
Not Applicable
Not yet recruiting
- Conditions
- Perineal DescentObstructed Defecation Syndrome (ODS)
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 20
- Registration Number
- NCT07039188
A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis
Phase 2
Not yet recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Tolerogenic dendritic cells (tolDC)
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 10
- Registration Number
- NCT07020715
- Locations
- 🇧🇪
Universitair Ziekenhuis Antwerpen (UZA), Edegem, Belgium
🇪🇸Germans Trias i Pujol Hospital (HUGTiP), Badalona, Spain
- Prev
- 1
- 2
- 3
- 4
- 5
- 45
- Next
News
No news found